MAPT and Parkinson disease: CSF biomarkers in PD, such as α-synuclein species, lysosomal enzymes, markers of amyloid and tau pathology, and neurofilament light chain, have been suggested to possess potential diagnostic and prognostic value of PD (Parnetti et al., 2019).